<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/259236-a-method-of-stabilising-a-ldh-insertion-mutation-and-inserting-one-or-more-expressibe-genes-into-ldh-gene by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:46:11 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 259236:A METHOD OF STABILISING A LDH INSERTION MUTATION AND INSERTING ONE OR MORE EXPRESSIBE GENES INTO LDH GENE</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">A METHOD OF STABILISING A LDH INSERTION MUTATION AND INSERTING ONE OR MORE EXPRESSIBE GENES INTO LDH GENE</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>A Gram-positive bacterium wherein the ethanol production characteristics have been enhanced through stabilization of ldh mutation using a plasmid integration method based on the homologous recombination of a plasmid and insertion element (IE) sequence within the native ldh gene.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>WO 02/29030	PCT/GBO1/04434<br>
Ethanol Production<br>
This invention relates to the production of ethanol as a product of bacterial fermentation. In<br>
particular this invention relates to a novel method of gene inactivation and gene expression<br>
based upon homologous recombination.<br>
Many bacteria have the natural ability to metabolise simple sugars into a mixture of acidic<br>
and neutral fermentation products via the process of glycolysis. Glycolysis is the series of<br>
enzymatic steps whereby the six carbon glucose molecule is broken down, via multiple<br>
intermediates, into two molecules of the three carbon compound pyruvate. The glycolytic<br>
pathways of many bacteria produce pyruvate as a common intermediate. Subsequent<br>
metabolism of pyruvate results in a net production of NADH and ATP as well as waste<br>
products commonly known as fermentation products. Under aerobic conditions,<br>
approximately 95% of the pyruvate produced from glycolysis is consumed in a number of<br>
short metabolic pathways which act to regenerate NAD+ via oxidative metabolism, where<br>
NADH is typically oxidised by donating hydrogen equivalents via a series of steps to<br>
oxygen, thereby forming water, an obligate requirement for continued glycolysis and ATP<br>
production.<br>
Under anaerobic conditions, most ATP is generated via glycolysis. Additional ATP can<br>
also be regenerated during the production of organic acids such as acetate. NAD+ is<br>
regenerated from NADH during the reduction of organic substrates such as pyruvate or<br>
acetyl CoA. Therefore, the fermentation products of glycolysis and pyruvate metabolism<br>
include organic acids, such as lactate, formate and acetate as well as neutral products such<br>
as ethanol.<br>
The majority of facultatively anaerobic bacteria do not produce high yields of ethanol either<br>
under aerobic or anaerobic conditions. Most facultative anaerobes metabolise pyruvate<br>
aerobically via pyruvate dehydrogenase (PDH) and the tricarboxylic acid cycle (TCA).<br>
Under anaerobic conditions, the main energy pathway for the metabolism of pyruvate is via<br>
the pyruvate-formate-lyase (PFL) pathway to give formate and acetyl-CoA. Acetyl-CoA is<br>
then converted to acetate, via phosphotransacetylase (PTA) and acetate kinase (AK) with<br><br>
WO 02/29030	PCT/GB01/04434<br>
2<br>
the co-production of ATP, or reduced to ethanol via acetaldehyde dehydrogenase (AcDH)<br>
and alcohol dehydrogenase (ADH). In order to maintain a balance of reducing equivalents,<br>
excess NADH produced from glycolysis is re-oxidised to NAD+ by lactate dehydrogenase<br>
(LDH) during the reduction of pyruvate to lactate. NADH can also be re-oxidised by AcDH<br>
and ADH during the reduction of acetyl-CoA to ethanol but this is a minor reaction in cells<br>
with a functional LDH. Theoretical yields of ethanol are therefore not achieved since most<br>
acetyl CoA is converted to acetate to regenerate ATP and excess NADH produced during<br>
glycolysis is oxidised by LDH.<br>
Ethanologenic microorganisms, such as Zymomonas mobilis and yeast, are capable of a<br>
second type of anaerobic fermentation commonly referred to as alcoholic fermentation in<br>
which pyruvate is metabolised to acetaldehyde and CO2 by pyruvate decarboxylase (PDC).<br>
Acetaldehyde is then reduced to ethanol by ADH regenerating NAD+ Alcoholic<br>
fermentation results in the metabolism of 1 molecule of glucose to two molecules of<br>
ethanol and two molecules of CO2. DNA which encodes both of these enzymes in Z.<br>
mobilis has been isolated, cloned and expressed recombinantly in hosts capable of<br>
producing high yields of ethanol via the synthetic route described above. For example; US<br>
5,000,000 and Ingram et al (1997) Biotechnology and Bioengineering 58, Nos. 2 and 3<br>
have shown that the genes encoding both PDC (pdc) and ADH (adh) from Z. mobilis can<br>
be incorporated into a "pet" operon which can be used to transform Escherichia coli strains<br>
resulting in the production of recombinant E. coli capable of co-expressing the Z. mobilis<br>
pdc and adh. This results in the production of a synthetic pathway re-directing E. coli<br>
central metabolism from pyruvate to ethanol during growth under both aerobic and<br>
anaerobic conditions. Similarly, US 5,554520 discloses thai pdc and adh from Z. mobilis<br>
can both be integrated via the use of a pet operon to produce Gram negative recombinant<br>
hosts, including Erwina, Klebsiella and Xanthomonas species, each of which expresses the<br>
heterologous genes of Z. mobilis resulting in high yield production of ethanol via a<br>
synthetic pathway from pyruvate to ethanol.<br>
US 5482846 discloses the simultaneous transformation of mesophilic Gram positive<br>
Bacillus sp with heterologous genes which encode both the PDC and ADH enzymes so that<br><br>
WO 02/29030	PCT/GB01/04434<br>
3<br>
the transformed bacteria produce ethanol as a primary fermentation product. There is no<br>
suggestion that bacteria transformed with the pdc gene alone will produce ethanol.<br>
EP-A-0761815 describes a method of homologous recombination whereby a sporulation<br>
gene is inserted into Bacillus thurengiensis.<br>
EP-A-0603416 describes a method of homologous recombination whereby an arbitary gene<br>
is inserted into Lactobacillus delbrueckii.<br>
EP-A-0415297 describes a method of producing Bacillus strains expressing a mutant<br>
protease.<br>
Biwas et al., (J. Bacteriol., 175, 3628-3635, 1993) describes a method of homologous<br>
recombination whereby Lactococcus lactis has a chromosomal gene replaced by a plasmid<br>
carried modified copy. The method uses a thermosensitive plasmid and cannot be used to<br>
transform a thermophilic bacterium.<br>
A key improvement in the production of ethanol using biocatalysts can be achieved with<br>
thermophilic microorganisms that operate at high temperature. The conversion rate of<br>
carbohydrates into ethanol is much faster. For example, ethanol productivity in a<br>
thermophilic Bacillus is up to ten-fold faster than a conventional yeast fermentation<br>
process which operates at 30°C. Consequently, a smaller production plant is required for a<br>
given volumetric productivity, thereby reducing plant construction costs. . At high<br>
temperature, there is a reduced risk of contamination in the fermenter from other<br>
microorganisms, resulting in less downtime, increased plant productivity and a lower<br>
energy requirement for feedstock sterilisation. Moreover, fermentation cooling is not<br>
required, reducing operating costs further. The heat of fermentation helps to evaporate<br>
ethanol, which reduces the likelihood of growth inhibition from high ethanol<br>
concentrations, a common problem with most bacterial fermentations. Ethanol evaporation<br>
in the fermenter head space also facilitates product recovery.<br><br>
WO 02/29030	PCT/GBO1/04434<br>
4<br>
The inventors' strain originates from a wild-type isolate that is a natural composting<br>
organism and far more suited for the conversion of sugars found in agricultural feedstocks<br>
to ethanol than traditional mesophilic microorganisms. The base strain possesses all the<br>
genetic machinery for the conversion of hexose and pentose sugars, and cellobiose to<br>
ethanol; the inventors have simply blocked the LDH pathway to increase ethanol yields.<br>
This process is called self-cloning and does not involve expression of foreign DNA.<br>
Consequently, the resulting organism does not fall under the safety regulations imposed on<br>
the use of genetically modified organisms (GMOs).<br>
In contrast, conventional biocatalysts are either good ethanol producers unable to utilise<br>
pentose sugars or poor ethanol producers that can utilise pentose sugars. These organisms<br>
have been genetically modified using complex genetic techniques so that they can convert<br>
both hexose and pentose sugars to ethanol. However, there are doubts about the stability of<br>
these recombinant organisms and concerns over safety since such organisms fall under the<br>
GMO safety regulations. Moreover, recombinant mesophiles have expensive nutrient<br>
requirements and are sensitive to high salt concentrations and feedstock inhibitors.<br>
The metabolic reactions leading to lactic acid formation (LDH pathway) have been blocked<br>
by chemical mutagenesis and the resulting strain TN is lactate negative and produces<br>
ethanol in high yield. However, the mutant strain is unstable and spontaneously reverts to<br>
the lactacte-producing wild-type. Revertants grow faster than the mutant at low pH and in<br>
high sugar concentrations, and rapidly 'take-over' in continuous culture. During<br>
'take-over', the main fermentation product changes from ethanol to lactate.<br>
The inventors initiated a molecular biology program to tackle the stability problem and<br>
gain a better insight into the genetic systems involved in ethanol formation. The inventors<br>
first developed genetic techniques to specifically manipulate the organism and a<br>
sporulation deficient mutant amenable to generic manipulation was then selected in<br>
continuous culture. The inventors then sequenced several key metabolic genes; lactate<br>
dehydrogenase (Idh), lactase permease (lp), alcohol dehydrogenase (adh) and a novel<br>
insertion sequence located within the Idh gene. DNA sequence analysis of the Idh gene<br>
from the chemically mutated strain revealed that the gene had been inactivated by the<br><br>
WO 02/29030	PCT/GB01/04434<br>
5<br>
insertion of a naturally occurring insertion sequence element (IE) (also referred to as an IS<br>
element) in the coding region of the gene. Transposition into (and out of) the Idh gene and<br>
subsequent gene inactivation is itself unstable, resulting in reversion.<br>
The inventors determined that the IE sequence within the Idh gene provides a large area for<br>
homologous recombination. It was therefore proposed that the stability of the Idh mutation<br>
could be improved by integration of plasmid DNA into the IE sequence already present<br>
within the Idh gene of strain TN.<br>
The stability of the Idh gene mutation was improved by specific homologous<br>
recombination between a plasmid and the insertion sequence within the Idh gene. The<br>
resulting strain is a sporulation deficient, facultatively anaerobic, Gram-positive Bacillus<br>
which exhibits improved ethanol production characteristics in continuous culture. Results<br>
show that this new type of mutant is completely stable and has superior growth<br>
characteristics and ethanol productivity than the first mutants generated by chemical<br>
mutagenesis.<br>
Strain improvement has been achieved through a novel method of gene integration based<br>
on homologous recombination. The site of integration and plasmid for recombination can<br>
also be used to integrate and overexpress native or heterologous genes.<br>
Southern hybridisation studies indicated that 3 copies of a transposable insertion sequence<br>
element (IE) are present on the chromosome of Bacillus strain LLD-R. The., insertion<br>
sequence is 3.2kb long and comprises three DNA open reading frame sequences (ORF's)<br>
that are potentially translatable into proteins. ORF1 exhibits no homology to any protein in<br>
the National Center for Biotechnology Information (NCBI) database<br>
(www.ncbi.nlm.nih.gov/) whereas istA and istB display significant homology to a family of<br>
known transposase enzymes. Bacillus strain TN was developed from LLD-R following<br>
chemical mutagenesis (Figures 9A and 9B), and one copy of the insertion sequence was<br>
found within the structural Idh gene resulting in inactivation of the Idh gene and a lactate<br>
negative phenotype, the main metabolic product of fermentation thereby changing from<br>
lactate to ethanol. The DNA sequence of the Idh gene and the IE sequence (underlined)<br><br>
WO 02/29030	PCT/GB01/04434<br>
6<br>
from Bacillus strain TN are shown in Fig. 1. The amino acid sequence of L-LDH is shown<br>
in Fig. 11.<br>
However, this insertion proved to be relatively unstable and the mutant strain TN<br>
spontaneously reverts back to strain TN-R with a functional Idh gene. The main metabolic<br>
product of fermentation changes from ethanol to lactate as shown in Fig. 2 which shows<br>
the genetic instability of Bacillus mutant strain TN.<br>
The IE sequence was amplified from TN chromosomal DNA by PCR. Primers were<br>
chosen from the Idh gene sequence that flanked the insertion sequence and a HindUl<br>
restriction site was introduced into the upstream primer and a Xbal restriction site was<br>
introduced into the downstream primer to create convenient restriction sites for subsequent<br>
cloning into plasmid pUBUC. A 3.2kb PCR fragment containing the insertion sequence<br>
was trimmed using HindIIIand Xbal restriction endonucleases and subsequently cloned<br>
into plasmid pUBUC resulting in plasmid pUBUC-IE (Figure 5).<br>
In vivo methylation of plasmid DNA to prevent its restriction after transformation of<br>
Bacillus sp. was achieved after transformation, propagation in and purification from E.<br>
coli TOP 10 cells harbouring plasmid pMETH. Methylated pUBUC-IE was then used to<br>
transform Bacillus strain TN. Transformants were first isolated on TGP agar plates<br>
(kanamycin) at 52°C. Transformants were then screened using PCR amplification of the<br>
Idh gene. Failure to amplify a PCR product (greater than 10 kb using set PCR conditions)<br>
using LDH primers suggested that at least one copy of the plasmid had become integrated<br>
into the chromosome.<br>
The new strain, TN-T9, was grown under pH controlled conditions in continuous culture<br>
without kanamycin selection to check for strain stability. Stability of strain TN-T9 was<br>
confirmed using sub-optimal fermentation conditions such that residual sugar was present<br>
within the fermentation medium; conditions which favour reversion. The fermentation ran<br>
continuously for 750 hours without any trace of lactate production despite the presence of<br>
residual sugar within the fermentation medium, pyruvate excretion and numerous<br>
deviations from the set conditions. Ethanol was produced in relatively large amounts<br><br>
WO 02/29030	PCT/GB01/04434<br>
7<br>
throughout the fermentation Fig. 4, indicating that the Idh gene mutation in strain TN-T9 is<br>
stable in continuous culture under the experimental conditions provided.<br>
The inventors have also optimised the fermentation conditions for cell growth and ethanol<br>
production for Bacillus strain TN-T9.<br>
In summary the inventors have developed a dual system for improving the stability of the<br>
Idh mutant whilst expressing pdc and adh genes optionally using a pdcladh operon. The<br>
inventors have also isolated and sequenced a novel Idh gene and insertion sequence<br>
element, as well as novel lactate permease and alcohol dehydrogenase genes. Furthermore,<br>
the inventors have developed a technique for the integration of plasmid DNA into the<br>
chromosome and selection of recombinant Bacillus sp and have developed a set of<br>
optimised conditions for the production of ethanol by bacterial fermentation.<br>
Accordingly, a first aspect of the present invention relates to a recombinant thermophilic,<br>
Gram-positive bacterium which has been transformed using a method of homologous<br>
recombination for stabilising a gene mutation and for inserting an expressible gene..<br>
The invention also provides a recombinant thermophilic, Gram-positive bacterium in<br>
which the stability of the Idh mutation has been enhanced by homologous recombination<br>
between a plasmid and the chromosomal DNA of the bacterium resulting in a strain for the<br>
production of ethanol as a product of bacterial fermentation.<br>
Preferably, the Gram-positive bacterium is a strain of B. thermoglucosidasius.<br>
Preferably, the Gram-positive bacterium has been transformed with a plasmid harbouring<br>
an BE sequence as set forth in Fig. 1, or a functional portion or variant thereof.<br>
Advantageously, the IE sequence of Fig. 1, or functional variant or portion thereof, is stably<br>
incorporated into the chromosome of the recombinant bacterium by homologous<br>
recombination.<br><br>
WO 02/29030	PCT/GB01/04434<br>
8<br>
Preferably, integration of the IE sequence into the chromosome of the recombinant<br>
bacterium will result in the inactivation of the native Idh gene.<br>
Preferably, the Gram-positive bacterium is Bacillus strain TN-T9 (NCIMB Accession no.<br>
NCIMB 41075 deposited on 8th September 2000 in accordance with the terms of the<br>
Budapest Treaty).<br>
Alternatively, it is preferred that the Gram-positive bacterium is Bacillus strain TN-TK<br>
(NCIMB Accession no. NCIMB 41115 deposited on 27th September 2001 in accordance<br>
with the terms of the Budapest Treaty).<br>
The present invention also relates to a Gram-positive bacterium obtained by selecting<br>
mutants of TN-T9 which are kanamycin sensitive. A suitable method for obtaining such,<br>
strains is described in the appended examples.<br>
Preferably, the Gram-positive bacterium is sporulation deficient.<br>
According to a second aspect of the present invention there is provided a Gram-positive<br>
bacterium wherein a native Idh gene has been inactivated by homologous recombination<br>
and one or more expressible genes have been inserted into the chromosomal DNA of the<br>
bacterium. Furthermore, gene expression may be increased by increased gene copy number<br>
following multiple insertions of the plasmid into the insertion sequence either as a result of<br>
one round or repeated rounds of integration.<br>
The one or more expressible genes may be inserted into one or more IE sequences present<br>
in the chromosomal DNA of the bacterium. For example, there are 3 IE sequences on the<br>
chromosome of strains TN-T9 and TN-TK.<br>
The gene to be expressed may be native to Bacillus such as alcohol dehydrogenase or<br>
foreign (i.e. heterlogous such as pyruvate decarboxylase from Z. mobilis and a-amylase<br>
from B. stearothermophilus. The genes may also be arranged in an operon under the same<br><br>
WO 02/29030	PCT/GB01/04434<br>
9<br>
transcriptional control. Gene expression may be regulated by manipulating the copy<br>
number of the gene and by using different transcriptional promoter sequences.<br>
Preferably, the one or more genes arepdc and/or adh.<br>
The amino acid sequence of adh is shown in Fig. 12.<br>
According to a third aspect of the invention there is provided a method of inactivating a<br>
native Idh gene and inserting one or more expressible genes into the chromosome of a<br>
bacterium by homologous recombination.<br>
Preferably the bacterium is a thermophilic Gram-positive bacterium.<br>
Preferably, the gene to be inactivated is a native Idh gene and the one or more expressible<br>
genes are a pdc gene and a adh gene. '	_	•<br>
Preferably, the pdc gene and the adh gene form part of a PDC operon operatively linked<br>
to the IE sequence of Fig. 1 on the same plasmid.	'<br>
Preferably the pdc gene is heterologous to the cell.<br>
Preferably, both the IE sequence of Fig. 1 and the PDC operon, or portions thereof, are<br>
stably integrated into the chromosome of the bacterium.<br>
Advantageously, the method of gene inactivation and expression comprises the use of a<br>
shuttle vector, as set forth in Fig. 5, which is able to replicate in E. coli and Bacillus strains<br>
at temperatures up to 54°C.<br>
According to a fourth aspect of the present invention there is provided a shuttle vector<br>
which is able to replicate in both E. coli and Bacillus sp at temperatures up to 54°C, which<br>
confers resistance to ampicillin and kanamycin and which harbours the IE sequence, or a<br>
portion thereof as set forth in Fig. 1, from Bacillus strain TN.<br><br>
WO 02/29030	PCT/GB01/04434<br>
10<br>
Preferably, the shuttle vector is pUBUC-E as set forth in Fig. 5.<br>
Preferably, the shuttle vector will contain a PDC operon comprising a pdc gene and a adh<br>
gene under the control of the Idh promoter and operably linked to the IE sequence of Fig. 1.<br>
According to a fifth aspect of the present invention there is provided a method of selecting<br>
for recombinant Bacillus sp at high temperature wherein plasmid DNA has been stably<br>
integrated into the Idh gene of the recombinant bacterium by homologous recombination,<br>
comprising use of PCR to select for recombinants that do not contain the native Idh gene<br>
and IE sequence.<br>
Preferably, successful integration of the insertion sequence into the Idh gene will be<br>
indicated by failure to amplify a PCR product from the Idh gene of the recombinant<br>
bacterium.<br>
The present invention also provides one or more polypeptides encoded by the sequence<br>
shown in Fig. 1 from nucleotide 652 to nucleotide 3800, or a functional variant or portion<br>
thereof, wherein the one or more polypeptides have the biological activity of a transposase.<br>
The one or more polypeptides may have the biological activity of a transposase taken alone<br>
or when combined with other polypeptides.<br>
Preferably, the one or more polypeptides has the amino acid sequence shown in Fig. 13,<br>
Fig. 14 or Fig. 15 or a functional portion or variant thereof.<br>
The functional portions or variants retain at least part of the transposase function of the<br>
polypeptide shown in Fig. 13, Fig. 14 or Fig. 15. Preferably the portions are at least 20,<br>
more preferably at least 50 amino acids in length. Furthermore, it is preferred that the<br>
variants have at least 80%, more preferably at least 90% and most preferably at least 95%<br>
sequence homology with the polypeptide shown in Fig. 13, Fig. 14 or Fig. 15. Homology<br>
is preferably measured using the BLAST program.<br><br>
WO 02/29030	PCT/GB01/04434<br>
11<br>
According to a sixth aspect of the invention there is provided a DNA sequence as set forth<br>
in Fig. 6, or a functional variant thereof, which codes for a polypeptide having the<br>
biological activity of the enzyme lactate dehydrogenase.<br>
According to a seventh aspect of the present invention there is provided a DNA sequence<br>
as set forth in Fig. 7B, or a functional variant thereof, which codes for a polypeptide having<br>
the biological activity of the enzyme lactate perm ease.<br>
According to an eigth aspect of the present invention there is provided a DNA sequence as<br>
set forth in Fig. 8, or a functional variant thereof, which codes for a polypeptide having the<br>
biological activity of the enzyme alcohol dehydrogenase.<br>
In this specification, functional variants include DNA sequences which as a result of<br>
sequence additions, deletions or substitutions, or which by virtue of the degeneracy of the<br>
genetic code, hybridise to and/or encode a polypeptide having a lactate dehydrogenase<br>
lactate permease or alcohol deydrongenase activity. Preferably, the variants have at least<br>
80%, more preferably 90% and most preferably 95% sequence homology to the sequence<br>
shown in the Figures. Homology is preferably measured using the BLAST program.<br>
A ninth aspect of the invention also provides a method for improving the stability of the<br>
Idh mutant comprising expressing genes using apdc/adh operon.<br>
A tenth aspect of the present invention relates to a technique for the integration and<br>
selection of recombinant Bacillus sp in accordance with the invention.<br>
According to the final eleventh aspect of the present invention there is provided a process<br>
for the production of ethanol by bacterial fermentation of the Gram-positive bacterium of<br>
the present invention comprising optimised fermentation conditions of pH, temperature,<br>
redox values and specific dilution rates for cell growth and ethanol production. Preferably,<br>
the fermentation conditions will comprise a pH range of between 5.5-7.5 and a temperature<br>
range of 40-75°C with redox values being between - 360 - 400 mV and dilution rates<br>
between 0.3 and 0.8h'.<br><br>
WO 02/29030	PCT/GB01/04434<br>
12<br>
Brief Description of the Drawings<br>
The production of recombinant bacteria in accordance with the present invention will now<br>
be described, by way of example only, with reference to the drawings in which:<br>
Fig. 1 shows the nucleotide sequence of a DNA sequence comprising an insertion element<br>
(IE), wherein the IE sequence is underlined;<br>
Fig. 2 is a schematic representation of the genetic instability of strain TN;<br>
Fig. 3 is a schematic representation of the method for LDH gene inactivation by<br>
single-crossover recombination in Bacillus mutant strain TN;<br>
Fig. 4 is a graphical representation showing the stability of Bacillus mutant strain TN-T9 in<br>
continuous culture for over 750 hours;<br>
Fig. 5 is a schematic representation of shuttle vector pUBUC-IE;<br>
Fig. 6 shows the DNA sequence of a novel lactate dehydrogenase gene and translated<br>
amino acid sequence from Bacillus strain LN;<br>
Fig. 7A shows the partial DNA sequence of a novel lactate permease gene and the<br>
translated amino acid sequence from Bacillus strain LN;<br>
Fig. 7B shows the full DNA sequence of a novel lactate permease gene and the translated<br>
amino acid sequence from Bacillus strain LN;Fig. 8 shows the DNA sequence of a novel<br>
alcohol dehydrogenase gene (underlined) from Bacillus strain LN;<br>
Fig. 9 is a schematic representation showing (A) the development of Bacillus strain TN-T9<br>
and (B) the development of Bacillus strains TN-T9 and TN-TK;<br>
Fig. 10 shows the construction of an artificial PDC operon;<br><br>
WO 02/29030	PCT/GB01/04434<br>
13<br>
Fig. 11 shows the amino acid sequence of L-lactate dehydrogenase (Idh) from the TN<br>
strain;<br>
Fig. 12 shows the amino acid sequence of alcohol dehydrogenase (adh) from the TN strain;<br>
Fig. 13 shows the amino acid sequence of a transposase encoded by the IE sequence.<br>
Fig. 14 shows the amino acid sequence of a transposase encoded by the IE sequence.<br>
Fig. 15 shows the amino acid sequence of a transposase encoded by the IE sequence.<br>
Examples<br>
Materials and Methods<br>
Construction of plasmid pUBUC<br>
A shuttle vector for the transfer of DNA between E. coli and the inventor's thermophilic<br>
Bacillus strains was developed by fusing plasmids pUC18 and pUBHO. Plasmid pUBHO<br>
is a widely used vector that was isolated from Staphyloccocus aureus which confers<br>
resistance to kanamycin and which can replicate in B. stearothermophilus at temperatures<br>
up to 54°C Narumi et al, 1992 Biotechnology Techniques 6, No. 1. Plasmids pUBl 10 and<br>
pUC18 were linearised with EcoRl and BamKl, and then ligated together to form pUBUC<br>
(6.4kb). Plasmid pUBUC has a temperature sensitive replicon, and cannot replicate above<br>
54°C making it an ideal host for gene integration, via homologous recombination at<br>
elevated temperatures.<br>
Construction of plasmid pMETH<br>
A 1.1kb fragment containing the met gene was amplified from Haemophilus aeygptius<br>
chromosomal DNA by PCR- The gene was verified by DNA sequencing. The met gene<br>
was trimmed with BamHL and Xbal, and then subcloned into the expression plasmid<br>
pCL1920, previously linearised with BamHl and Xbal. The resultant plasmid pMETH was<br>
transformed into E. coli TOP10. E. coli TOP10 cells harbouring pMETH were propagated<br>
and the culture was harvested for subsequent transformation and in vivo methylation using<br><br>
WO 02/29030	PCT/GB01/04434<br>
14<br>
a method described by Tang et al (1994) Nuc. Acid Res. 22 (14). Competent cells were<br>
stored in convenient aliquots at -70°C prior to transformation.<br>
PCR Amplification<br>
The IE sequence was amplified from TN chromosomal DNA by PCR using primers IDH7<br>
and LDH8. The concentration of reactants and the PCR procedure used were those<br>
recommended in the Expand™ High Fidelity PCR System (Roche Diagnostics). PCR<br>
amplification from lyophilised cells was achieved after 30 cycles in a Genius thermocycler<br>
(Techne, Ltd., Cambridge). The sequence of the upstream primer, LDH7, was<br>
5'-AAGCTT GAT GAA ATC CGG ATT TGA TGG-3' and the sequence of the<br>
downstream primer, LDH8 was 5'-TCTAGA GCT AAA TTT CCA AGT AGC-3'. These<br>
primers were chosen from the Idh gene sequence that flanked the insertion sequence. A<br>
HindlH. restriction site was introduced into the upstream primer and a Xbal restriction site<br>
was introduced into the downstream primer to create convenient restriction sites for<br>
subsequent cloning (introduced sites are underlined).<br>
Construction of plasmid pUBUC - IE<br>
The manipulation, transformation and isolation of plasmid DNA in E. coli was performed<br>
using standard procedures (Maniatis). A 3.2 kb PCR fragment containing the insertion<br>
sequence was trimmed with HindIII and XbaI and then cloned into plasmid pUBUC. The<br>
resulting shuttle plasmid, referred to as pUBUC-IE (Figure 5) can replicate in E.,coli and<br>
Bacillus strains at temperatures up to 54°C, confers resistance to ampicillin and kanamycin,<br>
and harbours the IE sequence from Bacillus strain TN.<br>
Construction of PDC Operon<br>
Bacillus strain TN converts the intracellular metabolite pyruvate to acetyl-CoA via the PFL<br>
or PDH pathway. Acetyl-CoA is then reduced to acetaldehyde and then to ethanol in<br>
reactions catalysed by AcDH and ADH, respectively. The introduction of a foreign PDC<br>
enzyme provides the cells with an alternative pathway for ethanol production that involves<br>
decarboxylation of pyruvate by PDC to form acetaldehyde which is then reduced to ethanol<br><br>
WO 02/29030	PCT/GB01/04434<br>
15<br>
by. the native ADH enzyme. Both PDC and ADH are involved in the conversion of<br>
pyruvate to ethanol.<br>
We have shown that expression of Z. mobilis pdc from plasmid pZP-1 improves cell<br>
grdwth and stability of the mutant strain TN. However, we did not see any significant<br>
increase in ethanol formation. Therefore, we decided to increase pdc gene expression and<br>
co-express the native adh gene from Bacillus TN.<br>
In plasmid pZP-1, the pdc gene was placed under the control of the Idh promoter sequence<br>
from B. stearothermophilus NCA1503. We decided to change the promoter with the Idh<br>
promoter from Bacillus LN (construct 1). We then placed the adh gene from Bacillus<br>
strain LN under the control of the Idh promoter (construct 2). Finally, both pdc (from Z.<br>
mobilis and adh (from Bacillus LN) were placed under the control of the Idh promoter<br>
sequence (construct 3). All the genes have been amplified by PCR from Z. mobilis (pdc)<br>
and Bacillus strain LN (Idh promoter and pdc), trimmed with the appropriate restriction<br>
enzymes, ligated together and cloned into an E. coli plasmid vector. The 3 constructs were<br>
cloned into the replicative shuttle vectors pUBUC, pFCl or the integrative shuttle vector<br>
pUBUC-IE for chromosomal integration.<br>
Example 1<br>
Transformation of TN<br>
Plasmid pUBUC-IE was methylated in vivo after transformation, propagation in and<br>
purification from E. coli TOP 10 cells harbouring plasmid pMETH. Methylated pUBUC-EE<br>
was then used to transform Bacillus strain TN. Bacillus strain TN cells were grown at<br>
65°C in 50ml of TGP medium until the absorbance at 600nm (A600) reached 0.5-0.6. The<br>
culture was chilled on ice for 15-30 min. The cells were harvested by centrifugation and<br>
washed once in 10ml and twice in 5ml of cold TH buffer (272mM trehalose and 8mM<br>
HEPES; pH 7.5 with KOH). The cell pellet was re-suspended in 400µl of TH buffer and<br>
stored at 4°C prior to electroporation. Methylated plasmid DNA was used to transform<br>
strain TN by electroporation based on a method previously described by Narumi et al<br>
(1992) Biotechnology Techniques 6(1). The competent cells were dispensed into 90µl<br><br>
WO 02/29030	PCT/GB01/04434<br>
16<br>
aliquots and mixed with 2µl of methylated plasmid DNA (250 ng/µl). The mixture was<br>
transferred to cold electroporation cuvettes (0.2cm electrode gap) and incubated on ice for<br>
5 minutes. The suspensions were then subjected to a 2.5kV discharge from a 25uF<br>
capacitor and the pulse control was set at 201 ohms (time constant, ז = 5 ms) using a<br>
EquiBio EasyJect electroporator. The cells were immediately transferred to 5ml of<br>
pre-warmed TGP, incubated at 52°C for lhr, and plated on TGP agar (lOµg/ml<br>
kanamycin). The plates were incubated for 24-48 hours at 52°C.<br>
Selection of Recombinants<br>
The following method was used to select for chromosomal integration of the temperature<br>
sensitive plasmid pUBUC-IE by homologous recombination.<br>
1.	Transformants were grown in 5ml of TGP (kanamycin) medium at 52°C for 24 hours.<br>
2.	50ml of fresh TGP (kanamycin) medium was inoculated with lml from O/N culture<br>
and incubated in a shaking water bath at 52°C until a ODwo was reached ~ 0.5.<br>
3.	15ml of the above culture was centrifuged at 4100 rpm for 5 min at 5°C and the pellet<br>
was resuspended in 150µl of TGP (10:g/ml kanamycin) medium and spread on TGP<br>
(kanamycin) plates.<br>
4.	The plates were incubated at 68°C for 16 hours.<br>
5.	The isolated colonies were picked and analysed for plasmid integration into the<br>
insertion sequence site by PCR.<br>
Screening of TN integrants<br>
TN integrants were isolated at 68°C. Failure to amplify a PCR product using LDH primers<br>
in TN integrants indicated that at least one copy of plasmid pUBUC-IE had become<br>
integrated into the chromosome. As a result of integration the new strain TN-T9 was found<br>
to be more stable with regard to Idh reversion and "take over" than the parental strain TN.<br><br>
WO 02/29030	PCT/GB01/04434<br>
17<br>
Stability of Strain TN-T9<br>
The fermentation was run under sub-optimal conditions such that residual sugar was<br>
present in the medium; conditions which favour reversion. The fermentation ran<br>
continuously for over 750 hours without any trace of lactate production despite residual<br>
sugar, pyruvate excretion and numerous deviations from the set conditions. Ethanol was<br>
produced in relatively large amounts throughout the fermentation. Kanamycin was not<br>
used to select for integratnts throughout the entire fermentation. These results indicate that<br>
the Idh gene mutation in TN-T9 is stable in continuous culture under the experimental<br>
conditions (pH 7.0,65°C with a 2% sugar feed).<br>
Ethanol Yields and Productivity<br>
The fermentation conditions have been optimised for ethanol production from glucose,<br>
xylose and glucose/xylose based feedstocks.<br>
Culture type:	continuous<br>
Temperature:	65°C<br>
pH:	6.8<br>
Sugar concentration in feed: 2-10%<br>
Sparge gas:	air<br>
Redox:	&gt;-350mV (controlled through air flow rate)<br>
Dilution rate:	0.36-0.6 h-1<br>
Under these conditions the ethanol yields obtained were between 0.4-0.5 g/g sugar.<br>
Ethanol productivities, using a dilution rate of 0.5h-1 were approximately 4 and 8 g<br>
ethanol/litre/hour on 2 and 4% sugar feeds, respectively.<br>
Example 2<br>
Selection of the kanamycin sensitive strain - TN-TK<br>
Bacillus TN-TK is a kanamycin sensitive derivative of TN-T9. This strain is completely<br>
stable with regard to the Idh mutation and an ideal host for plasmid borne expression<br>
involving kanamycin as a selectable marker.<br><br>
WO 02/29030	PCT/GB01/04434<br>
18<br>
TN-T9 was first grown at 68°C for 24 hours in 5ml of TGP supplemented with kanamycin<br>
(10µg/ml). Approximately 100ml of culture was spread on two TGP (Km) agar plates and<br>
incubated overnight at 68°C. Several hundred colonies were obtained and 100 were<br>
transferred to fresh TGP (Km) plates using a sterile toothpick. After overnight growth at<br>
68°C, the colonies were transferred (by replica plating) to fresh TGP plates and TGP (Km)<br>
plates and grown overnight at 68C.<br>
Two kanamycin sensitive colonies were obtained on TGP but not on the corresponding<br>
TGP (Km) plate. The Idh gene regions from these colonies were amplified by PCR and<br>
found to be comparable in size to the disrupted Idh gene from TN-T9 (parental strain). PCR<br>
was used to demonstrate that the strains had lost the gene conferring resistance to<br>
kanamycin. One derivative referred to as TN-TK was chosen for further growth<br>
experiments. These experiments confirmed that the kanamycin sensitivity and Idh mutation<br>
were completely stable.<br><br>
WO 02/29030	PCT/GB01/04434<br>
19<br>
Claims<br>
1.	A Gram-positive bacterium wherein the ethanol production characteristics have<br>
been enhanced through stabilisation of a Idh mutation using a plasmid<br>
integration method based on the homologous recombination of a plasmid and<br>
insertion element (IE) sequence within the native Idh gene.<br>
2.	A thermophilic Gram-positive bacterium which has been transformed using a method<br>
of homologous recombination for stabilising a gene mutation and for inserting an<br>
expressible gene.<br>
3.	A Gram-positive bacterium according to claim 1 which is a thermophilic.<br>
4.	A Gram-positive bacterium according to claim 1,2 or 3 wherein the bacterium is a<br>
Bacillus sp selected from B. stearothermophilits, B. calvodelox, B. caldotenax, B.<br>
thermoglucosidasins, B. coagulans, B. licheniformis, B. thermodenitrificans, and B.<br>
caldolyticus.<br>
5.	A Gram-positive bacterium according to any preceding claim wherein the Bacillus sp is<br>
B. thermoglucosidasius strain TN-T9 (NCIMB Accession No. NCIMB 41075).<br>
6.	A Gram-positive bacterium according to any one of claims 1 to 4 wherein the Bacillus<br>
sp is B. thermoglucosidasius strain TN-TK (NCIMB Accession No. NCIMB 41115).<br>
7.	A Gram-positive bacterium according to any one of the claims 1 to 6 wherein the<br>
bacterium has been transformed with a shuttle vector comprising the IE sequence, or a<br>
functional portion or variant thereof, as set forth in Fig. 1.<br>
8.	A Gram-positive bacterium according to claim 7 wherein the IE sequence, a functional<br>
or portion variant thereof, is stably incorporated into the chromosome of the<br>
recombinant bacterium by homologous recombination.<br><br>
WO 02/29030	PCT/GB01/04434<br>
20<br>
9.	A Gram-positive bacterium according to any preceding claim wherein a native Idh gene has been inactivated by homologous recombination.<br>
10.	A Gram-positive bacterium according to any preceding claim which is sporulation<br>
deficient.<br>
11.	A Gram-positive bacterium according to any preceding claim wherein the native Idh<br>
gene has been inactivated and which expresses a heterologouspcfc gene.<br>
12.	A Gram positive bacterium according to any one of claims 9,10 or11 wherein the<br>
native Idh gene has been irreversibly inactivated.<br>
13.	A method of inactivating -a native Idh gene and inserting one or more expressible<br>
genes comprising homologous recombination.<br>
14.	The method according to claim 13 wherein the one or more expressible genes are a<br>
pdc gene and a adh gene..<br>
15.	The method according to claim 14 wherein the pdc gene and the adh gene form part of<br>
a PDC operon operatively linked to the IE sequence of Fig. 1.<br>
16.	The method according to claim 13, 14 or 15 in which the heterologous/wfc gene is from<br>
a Zymomonas sp.<br>
17.	The method according to anyone of claims 13 to 16 in which the heterologous/Hfc<br>
gene is from Zymomonas mobilis.<br>
18.	The method according to any one of claims 14 to 17 wherein the adh gene is from<br>
Bacillus strain LN.<br><br>
WO 02/29030	PCT/GB01/04434<br>
21<br>
19.	The method according to anyone of claims 13 to 18 wherein an insertion sequence and<br>
a PDC operon, or portions thereof, are stably integrated into the chromosome of the<br>
recombinant bacterium.<br>
20.	The method according to anyone of claims 13 to 14 comprising using a shuttle vector,<br>
	as set forth in Fig. 5, which is able to replicate in E. coli and Bacillus strains.<br>
21.	A shuttle vector which harbours an IE sequence, or a portion thereof, as set forth in<br>
	Figure 1.<br>
22.	The shuttle vector according to claim 21 which harbours apdc gene operatively linked<br>
to the IE sequence of Fig. 1.<br>
23.	The shuttle vector according claim 22 wherein the pdc gene forms part of a PDC<br>
operon.<br>
24.	A method of selecting for a recombinant bacterium having an idh gene, wherein<br>
plasmid DNA has been stably integrated into the Idh gene of the bacterium by<br>
homologous recombination, comprising use of PCR to amplify the Idh gene.<br>
25.	A method according to claim 23, wherein failure to amplify a PCR product from the<br>
Idh gene of the recombinant bacterium indicates integration of the IE sequence as set<br>
forth in Fig. 1, or a portion thereof, into the chromosome of the recombinant bacterium.<br>
26.	A DNA sequence as set forth in Fig. 6,or-a-ftnetional variant thereof/which codes for<br>
a polypeptide having the biological activity of the enzyme lactate dehydrogenase.<br>
27.	A DNA sequence which hybridises to the DNA sequence of Fig. 6 under stringent<br>
conditions, or which is degenerate to the DNA sequence of Fig. 6 and which codes for a<br>
polypeptide having the activity of the enzyme lactate dehydrogenase.<br><br>
WO 02/29030	PCT/GB01/04434<br>
22<br>
28.	A DNA sequence as set forth in Fig. 7B,or-a-functional variant thereof, which codes<br>
	for a polypeptide having the biological activity of the enzyme lactate permease.<br>
29.	A DNA sequence which hybridises to the DNA sequence of Fig. 7B under stringent<br>
	conditions, or which is degenerate to the DNA sequence of Fig. 7B and which codes 	for a polypeptide having the activity of the enzyme lactate permease.<br>
30.	A DNA sequence as set forth in Fig. 8, or a functional variant thereof, which codes for<br>
	a polypeptide having the biological activity of the enzyme alcohol dehydfogenase.<br>
31.	A DNA sequence which hybridises to the DNA sequence of Fig. 8 under stringent<br>
	conditions, or which is degenerate to the DNA sequence of Fig. 8 and which codes for 	a polypeptide having the activity of the enzyme alcohol dehydrogenase.<br>
32	 A DNA sequence as set forth in Fig. 1 or a portion or functional variant thereof<br>
	which codes for one or more polypeptides having the biological activity of a<br>
	transposase, and has been classified as an insertion sequence.<br>
33.	An DNA sequence according to claim 32, wherein the sequence is from<br>
	thermophilic Bacillus strain TN.<br>
34.	One or more polypeptides encoded by the the sequence show in Fig. 1 from residue<br>
652 to residue 3800 or a functional variant or-portion-thereof wherein the one-or more<br>
polypeptides have the biological activity of a transposase.<br>
35.	A process for the production of ethanol by bacterial fermentation of the Gram-positive<br>
bacterium according to any one of claims 1 to 12 comprising using optimised<br>
fermentation conditions wherein the pH of the fermentation medium is within the range of pH 5.5-7.5.<br><br>
WO 02/29030	PCT/GB01/04434<br>
23<br>
36.	The process according to claim 35 wherein the pH of the fermentation medium is<br>
preferably between pH 6.0 - 7.0.<br>
37.	The process according to claim 35 or 36 wherein the pH of the fermentation medium<br>
is preferably between pH 6.4 - 6.9.<br>
38.	A process for the production of ethanol by bacterial fermentation of the Gram-positive<br>
bacterium according to any one of claims 1 to 12 comprising using optimised<br>
fermentation conditions wherein the temperature of the fermentation medium is within<br>
the range 40 - 75°C.<br>
39.	The process according to claim 38 wherein the temperature of the fermentation<br>
medium is preferably between 52 - 70°C.<br>
40.	The process according to claim 38 or 39 wherein the temperature of the fermentation<br>
medium is preferably between 60 - 68°C.<br><br>
41.	A process for the production of ethanol by bacterial fermentation comprising using air<br>
sparging within the culture such that the redox potential is between -360 and -400 mV.<br>
42.	The process according to claim 41 wherein the redox values are preferably between<br>
370 and -380 mV.<br>
43.	The proess according to claim 40 or 41 wherein the Gram-positive bacterium<br>
according to any one of claims 1 to 12.<br><br>
44.	A process for the continuous production of ethanol by bacterial fermentation of the<br>
Gram-positive bacterium according to any one of claims 1 to 12 in which the feed<br>
dilution rates are between 0.3-0.8 h-1.<br>
45.	A process according to claim 43 wherein the feed dilution rates are preferably between<br>
0.4 - 0.6 h-1.<br><br>
WO 02/29030	PCT/GB01/04434<br>
24<br>
46.	A process according to any one of claims 35 to 44 in which the bacterium used is<br>
	Bacillus strain TN.<br><br>
A Gram-positive bacterium wherein the ethanol production characteristics have been<br>
enhanced through stabilization of ldh mutation using a plasmid integration method based<br>
on the homologous recombination of a plasmid and insertion element (IE) sequence<br>
within the native ldh gene.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1hYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1jbGFpbXMucGRm" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZSBvdGhlcnMucGRm" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-correspondence others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1kZXNjcmlwdGlvbiBjb21wbGV0ZS5wZGY=" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-description complete.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1kcmF3aW5ncy5wZGY=" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-drawings.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1mb3JtIDEucGRm" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1mb3JtIDIucGRm" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1mb3JtIDMucGRm" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI2ODMta29sbnAtMjAwNy1mb3JtIDUucGRm" target="_blank" style="word-wrap:break-word;">02683-kolnp-2007-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgwNS0wMy0yMDEzKS1BTk5FWFVSRSBUTyBGT1JNLTMucGRm" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(05-03-2013)-ANNEXURE TO FORM-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgwNS0wMy0yMDEzKS1DTEFJTVMucGRm" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(05-03-2013)-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgwNS0wMy0yMDEzKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(05-03-2013)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgwNS0wMy0yMDEzKS1GT1JNLTEucGRm" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(05-03-2013)-FORM-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgwNS0wMy0yMDEzKS1GT1JNLTIucGRm" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(05-03-2013)-FORM-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgwNS0wMy0yMDEzKS1PVEhFUlMucGRm" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(05-03-2013)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgxNS0wMy0yMDEzKS1QRVRJVElPTiBVTkRFUiBSVUxFIDEzNy5wZGY=" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(15-03-2013)-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgzMC0xMC0yMDEzKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(30-10-2013)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgzMC0xMC0yMDEzKS1GT1JNLTEucGRm" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(30-10-2013)-FORM-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LSgzMC0xMC0yMDEzKS1QRVRJVElPTiBVTkRFUiBSVUxFIDEzNy5wZGY=" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-(30-10-2013)-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LUNPUlJFU1BPTkRFTkNFIE9USEVSUyAxLjEucGRm" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-CORRESPONDENCE OTHERS 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4My1LT0xOUC0yMDA3LUZPUk0gMTgucGRm" target="_blank" style="word-wrap:break-word;">2683-KOLNP-2007-FORM 18.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="259235-desulfurization-catalyst-for-catalytic-cracked-gasoline-method-of-producing-the-same-and-method-for-desulfurizing-of-catalytic-cracked-gasoline-using-the-same.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="259237-a-self-microemulsifiable-anhydrous-base-composition.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>259236</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>2683/KOLNP/2007</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>10/2014</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>07-Mar-2014</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>04-Mar-2014</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>18-Jul-2007</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>ELSWORTH BIOTECHNOLOGY LIMITED</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>AGROL HOUSE, WOODBRIDGE MEADOWS, GUILDFORD, SURREY GU1 1BA</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>CUSDIN, FIONA</td>
											<td>2 LADEN PARK, HORLEY, SURREY RH6 8DZ</td>
										</tr>
										<tr>
											<td>2</td>
											<td>JAVED, MUHAMMAD</td>
											<td>10 GREENSIDE, DAGENHAM, ESSEX RM8 1YB</td>
										</tr>
										<tr>
											<td>3</td>
											<td>MILNER, PAUL</td>
											<td>23 SUSEX ROAD, ICKENHAM, UXBRIDGE UB10 8PN</td>
										</tr>
										<tr>
											<td>4</td>
											<td>GREEN, EDWARD</td>
											<td>32 STATION ROAD, SHALFORD, GUILDFORD, SURREY GU4 8HB</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C12N 9/00</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/GB2001/004434</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2001-10-05</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>0024554.8</td>
									<td>2000-10-06</td>
								    <td>U.K.</td>
								</tr>
								<tr>
									<td>2</td>
									<td>60/247,017</td>
									<td>2000-11-13</td>
								    <td>U.K.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/259236-a-method-of-stabilising-a-ldh-insertion-mutation-and-inserting-one-or-more-expressibe-genes-into-ldh-gene by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:46:12 GMT -->
</html>
